Related references
Note: Only part of the references are listed.Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score
Hirotaka Iwaki et al.
MOVEMENT DISORDERS (2020)
The Parkinson's Disease Protein LRRK2 Interacts with the GARP Complex to Promote Retrograde Transport to the trans-Golgi Network
Alexandra Beilina et al.
CELL REPORTS (2020)
PINOT: an intuitive resource for integrating protein-protein interactions
James E. Tomkins et al.
CELL COMMUNICATION AND SIGNALING (2020)
LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
Gregor Bieri et al.
ACTA NEUROPATHOLOGICA (2019)
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
Mike A. Nalls et al.
LANCET NEUROLOGY (2019)
Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice
Laura Pellegrini et al.
HUMAN MOLECULAR GENETICS (2018)
Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci
Monica Y. Sanchez-Contreras et al.
MOLECULAR NEURODEGENERATION (2018)
α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain
Ruben Fernandez-Santiago et al.
MOVEMENT DISORDERS (2018)
LRRK2 kinase in Parkinson's disease
Dario R. Alessi et al.
SCIENCE (2018)
Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics
Farah H. Bardai et al.
PLOS BIOLOGY (2018)
Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice
Stefano Cataldi et al.
NPJ PARKINSONS DISEASE (2018)
Penetrance Estimate of LRRK2 p.G2019S Mutation in Individuals of Non-Ashkenazi Jewish Ancestry
Annie J. Lee et al.
MOVEMENT DISORDERS (2017)
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Diana Chang et al.
NATURE GENETICS (2017)
Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study
Lisa Wang et al.
NEUROBIOLOGY OF AGING (2017)
Functional mapping and annotation of genetic associations with FUMA
Kyoko Watanabe et al.
NATURE COMMUNICATIONS (2017)
A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling
Ramy H. Malty et al.
CELL SYSTEMS (2017)
Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans
Jesse Mez et al.
ALZHEIMERS & DEMENTIA (2017)
The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype
Seyyedmohsen Hosseinibarkooie et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study
Joanne Trinh et al.
LANCET NEUROLOGY (2016)
Reference-based phasing using the Haplotype Reference Consortium panel
Po-Ru Loh et al.
NATURE GENETICS (2016)
Next-generation genotype imputation service and methods
Sayantan Das et al.
NATURE GENETICS (2016)
A Compendium of Chromatin Contact Maps Reveals Spatially Active Regions in the Human Genome
Anthony D. Schmitt et al.
CELL REPORTS (2016)
Second-generation PLINK: rising to the challenge of larger and richer datasets
Christopher C. Chang et al.
GIGASCIENCE (2015)
The role of SNCA and MAPT in Parkinson disease and LRRK2 parkinsonism in the Tunisian Arab-Berber population
J. Trinh et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals
Xiaojuan Dan et al.
NEUROBIOLOGY OF AGING (2014)
The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
Michael G. Heckman et al.
NEUROBIOLOGY OF AGING (2014)
The Vps35 D620N Mutation Linked to Parkinson's Disease Disrupts the Cargo Sorting Function of Retromer
Jordan Follett et al.
TRAFFIC (2014)
Interaction of LRRK2 with kinase and GTPase signaling cascades
Joon Y. Boon et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
The Genetics of Parkinson's Disease: Progress and Therapeutic Implications
Andrew B. Singleton et al.
MOVEMENT DISORDERS (2013)
RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson's Disease Risk (vol 77, pg 425, 2013)
David A. MacLeod et al.
NEURON (2013)
A Search for SNCA 3′ UTR Variants Identified SNP rs356165 as a Determinant of Disease Risk and Onset Age in Parkinson's Disease
Lucia F. Cardo et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants
Teresa Botta-Orfila et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants
Chaodong Wang et al.
PARKINSONISM & RELATED DISORDERS (2012)
Genome-wide association study of conduct disorder symptomatology
D. M. Dick et al.
MOLECULAR PSYCHIATRY (2011)
Genomewide Linkage Study of Modifiers of LRRK2-Related Parkinson's Disease
Jeanne C. Latourelle et al.
MOVEMENT DISORDERS (2011)
WHAT GENETICS TELLS US ABOUT THE CAUSES AND MECHANISMS OF PARKINSON'S DISEASE
Olga Corti et al.
PHYSIOLOGICAL REVIEWS (2011)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review
L. Correia Guedes et al.
PARKINSONISM & RELATED DISORDERS (2010)
Genome-wide Linkage Screen in Familial Parkinson Disease Identifies Loci on Chromosomes 3 and 18
Xiaoyi Gao et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Genetic factors influencing age at onset in LRRK2-linked Parkinson disease
Yulia Golub et al.
PARKINSONISM & RELATED DISORDERS (2009)
Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis
John E. Landers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A genome-wide scan in an Amish pedigree with parkinsonism
S. L. Lee et al.
ANNALS OF HUMAN GENETICS (2008)
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
Jeanne C. Latourelle et al.
BMC MEDICINE (2008)
LRRK2 mutation in familial Parkinson's disease in a Taiwanese population:: clinical, PET, and functional studies
Chin-Hsien Lin et al.
JOURNAL OF BIOMEDICAL SCIENCE (2008)
LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study
Mary M. Hulihan et al.
LANCET NEUROLOGY (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal
Joaquim J. Ferreira et al.
MOVEMENT DISORDERS (2007)
Evaluation of LRRK2 G2019S penetrance -: Relevance for genetic counseling in Parkinson disease
S. Goldwurm et al.
NEUROLOGY (2007)
LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East:: Evidence of two distinct founding events beginning two millennia ago
Cyrus P. Zabetian et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Principal components analysis corrects for stratification in genome-wide association studies
Alkes L. Price et al.
NATURE GENETICS (2006)
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease
A Di Fonzo et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs
S Lesage et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
G2019S LRRK2 mutation in French and North African families with Parkinson's disease
S Lesage et al.
ANNALS OF NEUROLOGY (2005)
The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
EK Tan et al.
NEUROSCIENCE LETTERS (2005)
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism:: Evidence of a common founder across European populations
J Kachergus et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
WC Nichols et al.
LANCET (2005)
Share Paper
